Status: Recruiting
The Study of Ginkgo Leaf Dropping Pills and Huperzine a Injection Combined with Median Nerve Electrical Stimulation in the Treatment of Cognitive Impairment After Brain Injury
This study will conduct a single-center clinical trial to explore the initial therapeutic effect of ginkgo biloba dropping pills, huperzine A injection and median nerve electrical stimulation in patients with cognitive impairment.
Participants needed: 50
Trial details
Phase: Phase 4Age: 18-80Biological sex: AllType: InterventionalSponsor: Wanbangde Pharmaceutical Group Co., LTDUpdated: Dec 11, 2024Locations: 1
Eligibility criteria
Be over 18 years old [+2]
The patient had severe underlying disease and unstable vital signs [+1]